MRC1 and neoplasm: Consistent with their tumor-promoting functions, TAM expressing high levels of the scavenger receptor CD163 and the mannose receptor CD206/MRC1 are immunosuppressive and predictive of an early relapse of ovarian carcinoma after first-line therapy (13, –15).